MH
Michael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$34.8M
shares × price, as filed
Last traded
Jul 8
Filed Jul 10
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $38.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
13 filings
Sector per market data · by filing · past 12 months
Most traded names
APGERecent filings
APGESALE
Apogee Therapeutics, Inc.
View filing →
$620K13,328 sh × $46.50
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $828K
14,000 sh × $59.17
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET